HURA (TuHURA Biosciences) Accumulated Depreciation : $-2.09 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is TuHURA Biosciences Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

TuHURA Biosciences's quarterly accumulated depreciation declined from Jun. 2024 ($-2.04 Mil) to Sep. 2024 ($0.00 Mil) but then increased from Sep. 2024 ($0.00 Mil) to Dec. 2024 ($-2.09 Mil).

TuHURA Biosciences's annual accumulated depreciation increased from Dec. 2022 ($-1.79 Mil) to Dec. 2023 ($-1.97 Mil) and increased from Dec. 2023 ($-1.97 Mil) to Dec. 2024 ($-2.09 Mil).

TuHURA Biosciences Accumulated Depreciation Historical Data

The historical data trend for TuHURA Biosciences's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TuHURA Biosciences Accumulated Depreciation Chart

TuHURA Biosciences Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Accumulated Depreciation

-1.42

-1.79

-1.97

-2.09

TuHURA Biosciences Quarterly Data
	Dec21	Mar22	Dec22	Mar23	Dec23	Mar24	Jun24	Sep24	Dec24
Accumulated Depreciation	Get a 7-Day Free Trial				-1.97	-2.01	-2.04	-	-2.09

TuHURA Biosciences Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

TuHURA Biosciences Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of TuHURA Biosciences's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

TuHURA Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TuHURA Biosciences Inc (NAS:HURA) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

N/A

Address

10500 University Center Drive, Suite 110, Tampa, FL, USA, 33612

Website

https://www.tuhurabio.com

TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.